Aerami’s mission-driven approach to product development seeks to help patients live longer and live better by developing inhaled medications that leverage advanced administration platforms to support ease of use and quality of life.

We are developing therapies to address the unmet medical needs of people with serious and rare forms of pulmonary hypertension, including pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension.